Welch Allyn said its new Connex clinical surveillance system includes technology from a pair of rivals in the patient monitoring space, Masimo (NSDQ:MASI) and Covidien (NYSE:COV), as well as EarlySense.

The Connex platform, which transmits captured vital sign data directly into the patient’s electronic medical record, incorporates Masimo’s acoustic respiration technology, Microstream end-tidal carbon dioxide technology from Covidien and EarlySense’s contact-free motion, heart rate and respiratory rate monitoring, according to a press release.

"As hospitals struggle to remain competitive in the new healthcare system, they’ll need every advantage to provide better patient care at a lower cost. The pressure on clinicians will only escalate as new healthcare rules make the need to quickly identify changes in patient health even more important. Surveillance solutions like the Connex CSS, which is designed to fit within the workflow of med/surg units, can assist clinicians in meeting these requirements and have a positive effect on patient care. Designed specifically for med/surg floors, our new solution can help clinicians anticipate the worsening of an existing condition or the appearance of a new one—not just from within the patient’s room, but from a central monitoring station or even on a mobile phone," vital signs business unit senior VP Doug Linquest said in prepared remarks.

Welch Allyn said the Connex system includes a remote monitoring station and "leverages Welch Allyn’s extensive EMR partnerships to enable connectivity and increase access to accurate patient information."

The Skaneateles Falls, N.Y.-based medical device company said it’s also releasing a Connex service dashboard to help manage and maintain the system and its components.